![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
EU WC
0
Listed Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
1. (1-methyl-4,5-dihydroorotyl)-histidyl-prolinamide
2. Ta 0910
3. Ta-0910
4. Taltirelin Hydrate
1. 103300-74-9
2. Taltirelin Acetate
3. Ceredist
4. Ta 0910
5. Ta-0910
6. Taltirelin [inn]
7. Doz62mv6a5
8. (s)-n-((s)-1-((s)-2-carbamoylpyrrolidin-1-yl)-3-(1h-imidazol-4-yl)-1-oxopropan-2-yl)-1-methyl-2,6-dioxohexahydropyrimidine-4-carboxamide
9. Ncgc00181033-01
10. (4s)-n-[(2s)-1-[(2s)-2-carbamoylpyrrolidin-1-yl]-3-(3h-imidazol-4-yl)-1-oxopropan-2-yl]-1-methyl-2,6-dioxo-1,3-diazinane-4-carboxamide
11. (4s)-n-[(2s)-1-[(2s)-2-carbamoylpyrrolidin-1-yl]-3-(1h-imidazol-5-yl)-1-oxopropan-2-yl]-1-methyl-2,6-dioxo-1,3-diazinane-4-carboxamide
12. Unii-doz62mv6a5
13. Taltirelina
14. Taltireline
15. Taltirelinum
16. Ccris 8513
17. Taltirelin [mi]
18. Ta-0910, Taltirelin
19. Taltirelin [mart.]
20. (-)-n-(((s)-hexahydro-1-methyl-2,6-dioxo-4-pyrimidinyl)carbonyl)-l-histidyl-l-prolinamide
21. Dsstox_cid_23763
22. Dsstox_rid_80071
23. Taltirelin [who-dd]
24. Dsstox_gsid_43763
25. (1-methyl-4,5-dihydroorotyl)-histidyl-prolinamide
26. Schembl194528
27. Gtpl2143
28. Chembl2107016
29. Dtxsid0043763
30. Schembl21219549
31. Schembl22077031
32. Chebi:135653
33. Bcpp000053
34. Amy22588
35. Bcp02001
36. Hy-b0596
37. Zinc4217500
38. Tox21_112682
39. Akos015920135
40. Akos015969113
41. L-prolinamide, N-(((4s)-hexahydro-1-methyl-2,6-dioxo-4-pyrimidinyl)carbonyl)-l-histidyl-
42. L-prolinamide, N-((hexahydro-1-methyl-2,6-dioxo-4-pyrimidinyl)carbonyl)-l-histidyl-, (s)-
43. N-[[(4s)-hexahydro-1-methyl-2,6-dioxo-4-pyrimidinyl]carbonyl]-l-histidyl-l-prolinamide
44. Ncgc00381723-02
45. Ac-23956
46. Cas-103300-74-9
47. 300t749
48. J-000925
49. Q7680336
50. (1-methyl-(s)-4,5-dihydroorotyl)-l-histidyl-l-prolinamide
51. 1-methyl-(s)-4,5-dihydroorotyl-l-histidyl-l-prolinamide
52. Methyl5-(propan-2-yl)-1,2-oxazole-3-carboxylate
53. N-{[(4s)-1-methyl-2,6-dioxohexahydropyrimidin-4-yl]carbonyl}-l-histidyl-l-prolinamide
54. (s)-n-((s)-1-((s)-2-carbamoylpyrrolidin-1-yl)-3-(1h-imidazol-5-yl)-1-oxopropan-2-yl)-1-methyl-2,6-dioxohexahydropyrimidine-4-carboxamide
Molecular Weight | 405.4 g/mol |
---|---|
Molecular Formula | C17H23N7O5 |
XLogP3 | -3 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 6 |
Exact Mass | 405.17606686 g/mol |
Monoisotopic Mass | 405.17606686 g/mol |
Topological Polar Surface Area | 171 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 714 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 3 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Nootropic Agents
Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms. (See all compounds classified as Nootropic Agents.)